Hit Generation in TB Drug Discovery: From Genome to Granuloma-Reference-Cited by-同舟云学术

Hit Generation in TB Drug Discovery: From Genome to Granuloma

Published:2018-01-31 Issue:4 Volume:118 Page:1887-1916
ISSN:0009-2665
Container-title:Chemical Reviews
language:en
Short-container-title:Chem. Rev.

Author:

Yuan Tianao¹^ORCID,Sampson Nicole S.¹²^ORCID

Affiliation:

1. Department of Chemistry, Stony Brook University, Stony Brook, New York 11794-3400, United States

2. Stellenbosch Institute for Advanced Study (STIAS), Wallenberg Research Centre at Stellenbosch University, Stellenbosch 7600, South Africa

Funder

National Heart, Lung, and Blood Institute

National Institute of Allergy and Infectious Diseases

Stellenbosch Institute for Advanced Study, Stony Brook University

Publisher

American Chemical Society (ACS)

Subject

General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acs.chemrev.7b00602

Reference262 articles.

1. WHO “Global Tuberculosis Report 2016”, World Health Organization, 2017;http://www.who.int/tb/publications/global_report/en/accessed: 29 September 2017.

2. CDC “Tuberculosis Fact Sheets”, Centers for Disease Control and Prevention, 2014;https://www.cdc.gov/tb/publications/factsheets/general/ltbiandactivetb.htmaccessed: 22 December 2017.

3. WHO “Collaborative Framework for Care and Control of Tuberculosis and Diabetes”, World Health Organization, 2017;http://www.who.int/tb/publications/tb-diabetes-framework/en/accessed: 5 January 2018.

4. Tuberculosis

5. WHO “Multidrug-Resistant Tuberculosis (MDR-TB) 2016 Update”, World Health Organization, 2016;http://www.who.int/tb/challenges/mdr/mdr_tb_factsheet.pdfaccessed: 29 September 2017.

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Compounds Derived from 5‐Fluoropyridine and Benzo[b]thiophene: Killing Mycobacterium tuberculosis and Reducing its Virulence;Chemistry & Biodiversity;2024-09-13

2. Key challenges in TB drug discovery: A perspective;Bioorganic & Medicinal Chemistry Letters;2024-09

3. Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies;International Journal of Biological Macromolecules;2024-08

4. Uncovering the roles of Mycobacterium tuberculosis melH in redox and bioenergetic homeostasis: implications for antitubercular therapy;mSphere;2024-04-23

5. Small Peptide Conjugates of Benzothiazole‐2‐Carboxylic Acids Targeting DprE1 Against Tuberculosis;ChemistrySelect;2024-04-15